Bloodstream Infections in Patients With Rheumatoid Arthritis

Sabine Dieperink

Status: Completed

Conditions: Staphylococcus Aureus Bacteremia; Rheumatoid Arthritis

Treatments: Other: Risk factors in general population; Other: Risk factors in RA cohort

Study type: Observational

Funder types: Other

Identifiers

NCT03908086

RA-SAB2018

Details and patient eligibility

About

Study of incidence and risk factors of staphylococcus aureus bacteremia in patients with rheumatoid arthritis compared with the general population in a nationwide cohort of all adult members of the population from 1996 until 2017 using national registries

Enrollment: 6,000,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All members of the adult Danish population

Exclusion criteria

• Staphylococcus aureus bacteremia prior to inclusion.
• Rheumatoid arthritis diagnosed prior to inclusion.

Trial design

6,000,000 participants in 2 patient groups

RA patients

Description:

Incident patients with rheumatoid arthritis as identified by the Danish National Patient Registry and the rheumatology registry, DANBIO.

Treatment:

Other: Risk factors in RA cohort

General population

Description:

All other adults, as Identified by the Civil Registration System. Patients who develop RA contribute person-years in the general population cohort until RA diagnosis

Treatment:

Other: Risk factors in general population